TITLE

Implications for registry-based vaccine effectiveness studies from an evaluation of an immunization registry: a cross-sectional study

AUTHOR(S)
Mahon, Barbara E; Shea, Kimberly M; Dougherty, Nancy N; Loughlin, Anita M
PUB. DATE
January 2008
SOURCE
BMC Public Health;2008, Vol. 8, p160
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Background: Population-based electronic immunization registries create the possibility of using registry data to conduct vaccine effectiveness studies which could have methodological advantages over traditional observational studies. For study validity, the base population would have to be clearly defined and the immunization status of members of the population accurately recorded in the registry. We evaluated a city-wide immunization registry, focusing on its potential as a tool to study pertussis vaccine effectiveness, especially in adolescents. Methods: We conducted two evaluations - one in sites that were active registry participants and one in sites that had implemented an electronic medical record with plans for future direct data transfer to the registry - of the ability to match patients' medical records to registry records and the accuracy of immunization records in the registry. For each site, records from current pediatric patients were chosen randomly. Data regarding pertussis-related immunizations, clinic usage, and demographic and identifying information were recorded; for 11-17-year-old subjects, information on MMR, hepatitis B, and varicella immunizations was also collected. Records were then matched, when possible, to registry records. For records with a registry match, immunization data were compared. Results: Among 350 subjects from sites that were current registry users, 307 (87.7%) matched a registry record. Discrepancies in pertussis-related data were common for up-to-date status (22.6%), number of immunizations (34.7%), dates (10.2%), and formulation (34.4%). Among 442 subjects from sites that planned direct electronic transfer of immunization data to the registry, 393 (88.9%) would have matched a registry record; discrepancies occurred frequently in number of immunizations (11.9%), formulation (29.1%), manufacturer (94.4%), and lot number (95.1%.) Inability to match and immunization discrepancies were both more common in subjects who were older at their first visit to the provider site. For 11-17-year-old subjects, discrepancies were also common for MMR, hepatitis B, and varicella vaccination data. Conclusion: Provider records frequently could not be matched to registry records or had discrepancies in key immunization data. These issues were more common for older children and were present even with electronic data transfer. These results highlight general challenges that may face investigators wishing to use registry-based immunization data for vaccine effectiveness studies, especially in adolescents.
ACCESSION #
51485761

 

Related Articles

  • A Review of Factors Affecting Vaccine Preventable Disease in Japan. Norimitsu Kuwabara; Ching, Michael S. L. // Hawaii Journal of Medicine & Public Health;Dec2014, Vol. 73 Issue 12, p376 

    Japan is well known as a country with a strong health record. However its incidence rates of vaccine preventable diseases (VPD) such as hepatitis B, measles, mumps, rubella, and varicella remain higher than other developed countries. This article reviews the factors that contribute to the high...

  • In the mood for wiping out vaccine-preventable diseases. Fleck, Fiona // Bulletin of the World Health Organization;Apr2014, Vol. 92 Issue 4, p236 

    An interview with executive vice president of the Sabin Vaccine Institute, Ciro de Quadros, is presented. He discusses how he became interested in immunization while involved with a smallpox programme in Brazil in 1969, what disease surveillance and containment is and how he helped to develop...

  • Recommended Adult Immunization Schedule -- United States, October 2005--September 2006.  // MMWR: Morbidity & Mortality Weekly Report;10/14/2005, Vol. 54 Issue 40, pQ-1 

    Focuses on the recommended Adult Immunization Schedule in the U.S. for October 2005 to September 2006. Difference of the 2005-2006 schedule from the previous schedule; Recommended dose of tetanus diphtheria vaccine for people aged 50-64 years; Web sites to access for further information on...

  • A Comparison of National Infection and Immunization Estimates for Measles and Rubella. Bean, Judy A.; Burmeister, Leon F.; Paule, Charles L.; Isacson, Peter // American Journal of Public Health;Dec1978, Vol. 68 Issue 12, p1214 

    The article presents a comparison of the different methods used to gather data about the incidence and immunization estimates for measles and rubella in the U.S. The U.S. Immunization Survey is a primary source of national estimates on the immunization status of children less than 14 years old,...

  • Do Vaccines Save Lives? Yes They Do! LERNOUT, Tinne; THEETEN, Heidi; LEURIDAN, Elke; VAN DAMME, Pierre // Acta Medica Portuguesa;mar/abr2014, Vol. 27 Issue 2, p160 

    Since their introduction and widespread use, vaccines have been very successful in reducing morbidity and mortality of the diseases they target, at an individual level and through herd immunity. The impact on the mortality has been rapid and easy to measure for some diseases, such as diphtheria,...

  • Vaccine development strategies for improving immunization: the role of modern immunology. Levine, Myron M.; Sztein, Marcelo B. // Nature Immunology;May2004, Vol. 5 Issue 5, p460 

    An ideal vaccine has certain biological and physical characteristics. Technological advances have provided new strategies that may help the design of such a vaccine.

  • A Prospective Study of the Effectiveness of the New Zealand Meningococcal B Vaccine. Colleen Kelly; Richard Arnold; Yvonne Galloway; Jane OHallahan // American Journal of Epidemiology;Oct2007, Vol. 166 Issue 7, p817 

    The effectiveness of a new group B strain-specific meningococcal vaccine referred to as “MeNZB,” developed by Chiron Vaccines (Siena, Italy) in collaboration with the Norwegian Institute of Public Health, was assessed in a prospective observational study following a...

  • Acute viscerotropic disease following vaccination against yellow fever. Hayes, Edward B. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Oct2007, Vol. 101 Issue 10, p967 

    Summary: Acute viscerotropic disease following yellow fever vaccination (YEL-AVD) is a rare but serious complication of vaccination with 17D yellow fever vaccine. This paper reviews the existing literature regarding YEL-AVD and discusses possible etiologic mechanisms. A greater understanding of...

  • Vaccine Effectiveness Estimates, 2004-2005 Mumps Outbreak, England. Cohen, Cheryl; White, Joanne M.; Savage, Emma J.; Glynn, Judith R.; Yoon Choi; Andrews, Nick; Brown, David; Ramsay, Mary E. // Emerging Infectious Diseases;Jan2007, Vol. 13 Issue 1, p12 

    The United Kingdom and United States have recently experienced large outbreaks of mumps, which raises concerns about vaccine effectiveness. The effectiveness of the mumps component of the measles, mumps, rubella (MMR) vaccine was estimated using the screening method. In England from January 2004...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics